Photo by nci from unsplash
We read with interest the results of the PROACT (Prospective Randomized On-X Anticoagulation Trial) trial [(1)][1], which evaluated possible alternatives to standard warfarin therapy for carriers of a low-thrombogenicity mechanical… Click to show full abstract
We read with interest the results of the PROACT (Prospective Randomized On-X Anticoagulation Trial) trial [(1)][1], which evaluated possible alternatives to standard warfarin therapy for carriers of a low-thrombogenicity mechanical heart valve (MHV). We comment on some aspects of the study design,
Keywords:
mechanical heart;
low thrombogenicity;
thrombogenicity mechanical;
heart valves
Journal Title: Journal of the American College of Cardiology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!